Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1953 1
1962 1
1965 1
1966 1
1968 1
1969 1
1970 1
1971 1
1972 2
1973 2
1974 2
1975 3
1976 5
1977 10
1978 9
1979 5
1981 1
1983 1
1985 2
1986 6
1987 2
1988 1
1989 1
1990 2
1991 12
1992 7
1993 9
1994 8
1995 17
1996 11
1997 4
1998 5
1999 8
2000 6
2001 4
2002 3
2003 4
2004 6
2005 3
2006 8
2007 9
2008 9
2009 6
2010 7
2011 11
2012 17
2013 13
2014 18
2015 15
2016 11
2017 22
2018 22
2019 15
2020 11
2021 13
2022 7
2023 7
2024 7
2025 9
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

384 results

Results by year

Filters applied: . Clear all
Page 1
Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B.
Pipe SW, Leebeek FWG, Recht M, Key NS, Castaman G, Miesbach W, Lattimore S, Peerlinck K, Van der Valk P, Coppens M, Kampmann P, Meijer K, O'Connell N, Pasi KJ, Hart DP, Kazmi R, Astermark J, Hermans CRJR, Klamroth R, Lemons R, Visweshwar N, von Drygalski A, Young G, Crary SE, Escobar M, Gomez E, Kruse-Jarres R, Quon DV, Symington E, Wang M, Wheeler AP, Gut R, Liu YP, Dolmetsch RE, Cooper DL, Li Y, Goldstein B, Monahan PE. Pipe SW, et al. Among authors: cooper dl. N Engl J Med. 2023 Feb 23;388(8):706-718. doi: 10.1056/NEJMoa2211644. N Engl J Med. 2023. PMID: 36812434 Clinical Trial.
A weekly low-dose regimen of decitabine and venetoclax is efficacious and less myelotoxic in a racially diverse cohort.
Goldfinger M, Mantzaris I, Shastri A, Saunthararajah Y, Gritsman K, Sica RA, Kornblum N, Shah N, Levitz D, Rockwell B, Shapiro LC, Gupta R, Pradhan K, Xue X, Munoz A, Dhawan A, Fehn K, Comas M, Verceles JA, Jonas BA, Kambhampati S, Shi Y, Braunschweig I, Cooper DL, Konopleva M, Feldman EJ, Verma A. Goldfinger M, et al. Among authors: cooper dl. Blood. 2024 Nov 28;144(22):2360-2363. doi: 10.1182/blood.2024025834. Blood. 2024. PMID: 39316768 Free PMC article. Clinical Trial.
A Metabolically Optimized, Noncytotoxic Low-Dose Weekly Decitabine/Venetoclax in MDS and AML.
Levitz D, Saunthararajah Y, Fedorov K, Shapiro LC, Mantzaris I, Shastri A, Kornblum N, Sica RA, Shah N, Konopleva M, Gritsman K, Braunschweig I, Cooper DL, Pradhan K, Verma A, Feldman EJ, Goldfinger M. Levitz D, et al. Among authors: cooper dl. Clin Cancer Res. 2023 Aug 1;29(15):2774-2780. doi: 10.1158/1078-0432.CCR-23-0842. Clin Cancer Res. 2023. PMID: 37341641
Introduction.
Cooper DL. Cooper DL. Mol Diagn. 1996 Jun;1(1):1-3. doi: 10.1054/MODI00100001. Mol Diagn. 1996. PMID: 10330193 No abstract available.
Refractory DLBCL: Challenges and Treatment.
Goldfinger M, Cooper DL. Goldfinger M, et al. Among authors: cooper dl. Clin Lymphoma Myeloma Leuk. 2022 Mar;22(3):140-148. doi: 10.1016/j.clml.2021.09.011. Epub 2021 Sep 20. Clin Lymphoma Myeloma Leuk. 2022. PMID: 34666950 Review.
Venetoclax plus daunorubicin and cytarabine for newly diagnosed acute myeloid leukemia: results of a phase 1b study.
Mantzaris I, Goldfinger M, Uriel M, Shastri A, Shah N, Gritsman K, Kornblum NS, Shapiro L, Sica RA, Munoz A, Chambers N, Dhawan A, Verceles JA, Fehn K, Tirone B, Shah L, Clark S, Zhang C, Kim M, Cooper DL, Verma A, Konopleva M, Feldman EJ. Mantzaris I, et al. Among authors: cooper dl. Blood. 2025 Apr 24;145(17):1870-1875. doi: 10.1182/blood.2024026700. Blood. 2025. PMID: 39919267 Free PMC article. Clinical Trial.
Chlorambucil-induced seizures.
Salloum E, Khan KK, Cooper DL. Salloum E, et al. Among authors: cooper dl. Cancer. 1997 Mar 1;79(5):1009-13. doi: 10.1002/(sici)1097-0142(19970301)79:5<1009::aid-cncr18>3.0.co;2-5. Cancer. 1997. PMID: 9041164 Review.
Traumatic Bursitis.
Cooper DL, Fair J. Cooper DL, et al. Phys Sportsmed. 1978 May;6(5):147. doi: 10.1080/00913847.1978.11710727. Phys Sportsmed. 1978. PMID: 27421461 No abstract available.
Female athletics.
Corbitt RW, Cooper DL, Erickson DJ, Kriss FC, Thornton ML, Craig TT. Corbitt RW, et al. Among authors: cooper dl. JAMA. 1974 Jun 3;228(10):1266-7. JAMA. 1974. PMID: 4406514 No abstract available.
Turf Toe.
Cooper DL, Fair J. Cooper DL, et al. Phys Sportsmed. 1978 Sep;6(9):139. doi: 10.1080/00913847.1978.11710764. Phys Sportsmed. 1978. PMID: 27437752 No abstract available.
384 results